AcuityMD is a commercial platform built for the medical technology industry. Thousands of sales and marketing professionals use AcuityMD to identify target markets, surface top opportunities, and grow their business.

• Branding, positioning and messaging
• Presentation design
• Web design & development
• Collateral, display graphics
• Social media & email 

Make the most of each opportunity and meeting that you get at LSI. Tighten your pitch deck storytelling and visuals. Elevate your social media presence. Make sure your message is simple to understand. See if www.alluviastudio.com can help you get there quickly and easily.

AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents — including equity research, earnings calls, expert interviews, filings, news, and internal proprietary content. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows with high quality outputs. With AI solutions like Generative Search, Generative Grid, and Deep Research, AlphaSense delivers the clarity and depth professionals need to navigate complexity and obtain accurate, real-time information quickly. For more information, visit ,www.alpha-sense.com.

Aptyx is a global medtech CDMO supporting a range of clinical markets, with particular expertise in complex interventional systems and transcatheter implants. Through Aptyx Interventional Systems, we partner with innovators from early-stage concept and feasibility through clinical, commercialization, and manufacturing at scale - bringing deep experience in covered stents and frames, catheter-based delivery systems, and integrated implant-delivery solutions.

Our teams work at the system level, aligning implant and delivery system design early to improve performance, reduce risk, and accelerate time to market. This approach is supported by the broader Aptyx network with seamless access to specialized capabilities including design & development.

With a collaborative, engineering-led mindset and a proven track record supporting both startups and global strategics, Aptyx helps emerging technologies move forward with greater speed, confidence, and scalability. Learn more at Aptyx.com or follow @Aptyx on LinkedIn.

Founded in 1994, Biomerics is a leading vertically integrated medical device contract manufacturer serving the interventional device market. Trusted as a vertically integrated partner with extensive engineering expertise and solutions, Biomerics supplies 20 of the top 30 medical device OEMs globally. Biomerics provides engineering design and development services, technology transfer manufacturing services, and contract manufacturing services — including sterilization and packaging — for medical device components, subassemblies and finished medical devices. Through nine locations in the United States, two in Costa Rica and one in the Dominican Republic, Biomerics meets customers’ immediate and long-term strategic needs. With comprehensive engineering Centers of Excellence, Biomerics is a leader in performance materials, interventional medical plastics, precision extrusion, micromachining of metals and polymers, laser processing, balloons and balloon catheters, advanced catheters and steerables, guidewires, image guided intervention, micro-overmolding, micro precision stamping, metal injection molding (MIM), and complex microassembly and finished device assembly. In addition to operating under a certified ISO 13485:2016 quality system, Biomerics is FDA registered and compliant with FDA 21 CFR Part 820.

Cedars-Sinai Intellectual Property Company helps turn ideas developed by our faculty into viable innovations. Its patent portfolio generates millions of dollars each year to support Cedars-Sinai’s basic and translational biomedical research efforts.

The Cedars-Sinai Accelerator assists growing healthcare startup companies in tailoring their solutions for maximum impact, with mentorship, funding and access to the resources, personnel and network of a world-class academic medical center.

Cedars-Sinai Health Ventures invests in the expansion of companies with viable products and services likely to be adopted by Cedars-Sinai.

Drummond Scientific Company, based near Philadelphia, is a leading life science manufacturing partner with over 75 years of proven expertise. Specializing in custom, high-throughput automated solutions, Drummond sets the industry standard for precision in diagnostic device manufacturing. Drummond is dedicated to advancing life science innovation by enabling faster, more scalable, and capital-efficient production. Through its venture manufacturing model, Drummond selectively invests in early-stage partners to bring breakthrough technologies to market—offering the infrastructure, expertise, and strategic support needed to accelerate commercialization.

As the medtech industry advances with renewed vigor, traditional capabilities are being outpaced by today’s rapid-fire market. To thrive, medtech companies must proactively transform their strategies around digitalization, innovation, supply chain, market capitalization, ESG, and much more. The EY Medtech team helps clients reimagine their end-to-end business ecosystem to enable both superior care delivery and sustained growth, shaping the future with confidence.

Greenberg Traurig (GT) is an international law firm with more than 3,000 attorneys across 51 offices worldwide. Our multidisciplinary team helps clients—from startups to global companies—navigate the complex legal and regulatory challenges that arise at the intersection of science, technology, and health care. We have deep knowledge of the frameworks governing the life sciences and health care sectors, including those set by the FDA and other governmental agencies, and extensive experience managing high-stakes litigation, from single claims to multidistrict matters and mass torts.

GT has a well-established record of developing robust global patent portfolios for medical device and digital health startups that can withstand the scrutiny of diligence and litigation, including some of the most disruptive technologies in MedTech over the last 15 years. In recent years, our team has served as counsel in several landmark transactions, including the #1 and #2 MedTech acquisitions of private companies in 2024, the #1 overall MedTech acquisitions in 2022 and 2024, and the largest MedTech acquisition in the history of Israel. By combining the firm’s collective experience in health care, intellectual property, regulatory, corporate, litigation, and governmental affairs, GT provides clients with innovative, informed, and practical legal strategies to support their business objectives—from discovery through product marketing and beyond.

Introducing Johnson & Johnson’s corporate venture capital organization, JJDC

JJDC finds transformative ideas and helps them mature into potential solutions for today’s patients.

Guided by a clear, consistent investment strategy aligned with the scientific goals of Johnson & Johnson, JJDC works hand-in-hand with partners to help navigate the path to creating breakthrough health innovations.
We invest across sectors—pharmaceuticals and medtech—and at all stages, from new company creation and seed-level startups to Series A and beyond, including private investments in public equity (PIPEs). Learn more about how we invest and take a look at the JJDC Portfolio.

All of our portfolio companies receive the same unwavering commitment to drive science and technology towards translation for patient benefit. We take a long-term approach, deploying the full capabilities of Johnson & Johnson, including discovery, clinical development, regulatory affairs, manufacturing and commercialization.

Our team includes leaders in the healthcare and technology communities, many with deep R&D experience. This gives us the ability to understand our partners and provide the help they need.

Every opportunity is unique, with tailored roles and terms that provide the best path to potential success.

Key Tech is a leading product development firm specializing in complex medical devices and regulated products. We partner with innovative medtech companies, from early-stage ventures to global strategics, to transform breakthrough ideas into commercially successful, manufacturable products.
Our multidisciplinary teams integrate human-centered design, industrial design, mechanical and electrical engineering, embedded systems, software, fluidics, optics, and systems engineering to solve technically demanding challenges. We support programs from early feasibility and concept development through detailed engineering, verification/validation, and transfer to manufacturing.
Key Tech has deep experience across surgical systems, energy-based devices, diagnostics, drug delivery, wearables, fluid management, and capital equipment. We are particularly strong in high-complexity electromechanical systems and user-critical applications in oncology, cardiovascular, women’s health, urology, and other specialized markets.
With a track record of helping clients de-risk technology, accelerate timelines, and elevate user experience, Key Tech serves as a trusted development partner for companies seeking to bring differentiated medical technologies to market.

Medmarc is the leading expert in the products liability risks facing medical technology and life sciences companies.  Medical technology and life sciences companies are vulnerable to a variety of products liability risks that are unique to their industry. We understand these risks and specialize in providing insurance and risk management solutions designed to respond to the industry's particular needs.

MedtechWOMEN, is a nonprofit organization dedicated to advancing women leaders across the medical technology industry. Through high-impact events, thought leadership programs, and an engaged community, MedtechWOMEN brings together executives, innovators, and investors who are shaping the future of healthcare. Its flagship annual conference, MedtechVISION, along with regional networking events and leadership initiatives, fosters connection, visibility, and inspiration among women driving innovation in medtech.

Morrison Foerster’s cross-disciplinary team of Life Sciences + Healthcare lawyers work with innovators at every phase of their growth cycle, from conception to commercialization and exit. As partner to some of the leading life sciences innovators, we support our clients’ groundbreaking ideas and help them discover the real-world solutions that will bring those ideas to life. Our global team includes 200+ attorneys, patent agents, and scientific advisors with 100+ advanced scientific and engineering degrees, including 70 Ph.D.s in life sciences and related engineering disciplines. We have deep experience in technologies such as pharmaceuticals, biosimilars, diagnostics, precision medicine, cell and gene therapies, medical devices, AI, and vaccines, amongst others. As trusted business advisors, we provide strategic counsel in emerging company/venture capital, M&A, IP strategy, FDA regulatory and compliance, privacy, transactions and licensing, and litigation.

Visit the MoFo Life Sciences Blog (https://lifesciences.mofo.com/), where we share legal and business insights and in-depth analyses to keep you informed of the trends and the complex technologies at the heart of the global pharmaceutical, biotechnology, diagnostics, medical devices, and digital health fields.

The New England Medical Innovation Center (NEMIC) is a 501(c)(3) nonprofit serving as the region’s premier innovation hub that accelerates healthcare technologies, workforce development, and ecosystem collaboration. We serve as a convenor, connecting  entrepreneurs, startups, industry leaders, academic institutions, healthcare organizations, and government partners to transform promising ideas into real-world impact.  Through accelerator programs, expert advisory services, commercialization support, industry events, and strategic partnerships, NEMIC helps innovators navigate the complex path from concept to market. Our work strengthens the healthcare and life sciences ecosystems while creating pathways to high-value careers, supporting business growth, and driving regional competitiveness.  By bringing together the people, resources, and expertise needed to solve healthcare's toughest challenges, NEMIC is building a healthier, more innovative, and more prosperous future for all.

We partner with Life Science startups and investors worldwide to accelerate and derisk transformational innovation on the path to clinical and commercial success. Whether your goals are focused on commercialization, IPOs, or strategic exits, we are here to help tailor our expertise to meet your specific needs. As highly experienced operators, we go beyond consultancy to bring a hands-on approach to every project. Our team's wealth of functional experience is dedicated to realizing your ideas and bringing them successfully to the market.

Innovative medical technologies change lives- but only when patients can access them.

Too often, breakthrough innovations stall due to unclear reimbursement pathways and misaligned stakeholder expectations. Without early, deliberate access strategy, adoption is delayed and patient access is at risk. This is where PRIA comes in….

PRIA Healthcare partners with MedTech innovators to translate breakthrough ideas into reimbursed, scalable care. Founded more than 14 years ago in patient access operational support services, PRIA began by helping facilities and providers through prior authorization and appeals management, for novel technologies, ultimately enabling access for more than 40,000 patients.

Today, PRIA is a full-spectrum partner across reimbursement, market access, and regulatory strategy, supporting companies from early concept through commercialization. Our integrated capabilities – spanning strategic reimbursement, health economics, market access strategy, patient access, payer engagement, regulatory, and quality – are designed to connect evidence, policy, and provider economics, accelerating the adoption of healthcare innovation.

PRIA helps ensure that innovation doesn’t stall at approval- but reaches providers, scales in practice, and ultimately reaches patients.

Advancing Innovation. Unlocking Access. Delivering Impact.

Medtech organizations are undergoing unprecedented changes. Supply chain disruption, enhanced regulation, high healthcare costs, counterfeit products, cybersecurity issues and R&D challenges are just a few of the obstacles medical device manufacturers and suppliers face today. These market changes also bring opportunities to generate value and growth beyond historic industry norms.

Our team helps medtech companies streamline operations, develop innovative products, and deliver life-saving solutions to patients. 

Ranfac is a single-source CDMO for Class I and Class II medical devices. It machines metal, molds polymer, assembles in-cleanroom, and delivers EO-sterile finished devices from one ISO 13485 / MDSAP facility in Avon, Massachusetts, with deep heritage in needle- and hypodermic-based devices and the ability to build all-polymer devices as well.

RBrooks Group works exclusively in the Med-Tech industry to source, assess and place top talent in the United States and Europe. Roger Brooks and his team have over 80 years of combined experience assisting early stage and established medical device organizations identify and hire the best C-Suite, board member and vice president executives. We pride ourselves on our reputation and strive to be the most highly regarded executive search firm in the medical device industry

RQM+ is a global MedTech service provider focused on accelerating compliance and market success.

Through our unparalleled expertise and industry knowledge, we deliver specialized solutions and expedite the journey along the full product lifecycle for Med Device and IVD companies, from concept to commercialization to post-market.

Our portfolio of services enables the delivery of end-to-end solutions across the complete med device product lifecycle, with our:

✓ Regulatory and Quality Consulting

✓ Lab Services (Jordi Labs)

✓ Clinical Trials

✓ Reimbursement

✓ Technology Solutions

Santé invests at the forefront of Healthcare and Technology Innovation, managing over one billion in capital. Santé invests in innovative, early-stage healthcare companies across the Biotech, Medtech, and Healthtech industries.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.

Based in Paris, London, and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical, and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage.
The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.

Founded in 1972, Sofinnova Partners is deeply established in Europe, with more than 50 years of experience backing over 500 companies and creating market leaders around the globe.

Today, Sofinnova Partners manages over €4 billion in assets.

Sonder Capital invests in teams and technologies that can transform healthcare in the medical
device, diagnostic, and healthtech sectors.

They are foundational investors, committing their energy and capital early to guide and support
companies from inception to acquisition or IPO. Core to their success is their ability and
willingness to be actively engaged with portfolio companies, partnering with entrepreneurs as
strategic advisors, providing more than just capital. 

Their insight into what it takes to bring innovative technologies to market stems from decades
of operating experience in the medtech industry. As founders, executives, and board members,
they have experienced and overcome many of the hurdles faced by entrepreneurs and
innovators.

Stifel Bank is a full-service financial partner dedicated to supporting the innovation ecosystem. Our life science and healthcare venture banking platform gives founders and investors the banking tools, lending solutions, and partnership they need to scale. Powered by an industry-leading investment bank and premier wealth management practice, Stifel bridges the gap between breakthrough ideas and lasting success. Stifel Venture Banking is a division of Stifel Bank, Member FDIC. Learn more at www.bankwithstifel.com.

Founded in 1992, The Mullings Group went all in on medtech, healthtech, and life sciences because we saw where the future was headed: people living longer, wanting to live healthier, and technology always seeking higher ground. Since then, we’ve completed over 9,000 successful placements across 900+ companies globally, with a search team that has over 100 years of combine tenure at TMG.

We deliver outcomes across three core areas: executive search, media & marketing, and advisory. Our consultative approach to search identifies and secures the right people at the right time, from individual contributors to C-suite and board roles, utilizing our proprietary tools and trademarked strategies aligned with your organization’s goals. Our advisory services support client-partners on organizational development, succession planning, and strategic initiatives that align people, story, and strategy.

As the only search firm in the world with a full media & marketing arm, we understand how critical it is to tell our clients’ stories at scale. Through Dragonfly, A TMG Company, our 9x award-winning media team develops hiring brands, thought leadership, and positioning strategies that attract talent, capital, and market attention.

With over 300,000 followers on LinkedIn, we’ve established ourselves as the trusted voice and partner in the industry.

Headquartered in Delray Beach, FL, with offices across the U.S., the UK, and Israel, we continue to expand alongside the companies driving innovation in medtech and emerging high-tech industries.

TVM Capital Life Science (“TVM”) is a leading international venture capital firm focused on investing in life science innovations.  The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. 

TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics. 

With its late-stage investments, TVM focuses on differentiated medical technologies with commercial proof-of-concept as well as late-stage therapeutics expected to quickly reach major development or regulatory milestones. This strategy has been validated through a number of companies in both Fund I and II and the Colucid Pharmaceuticals exit.  

The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.